Comparative study of full-length and B-domain deleted factor VIII concentrates [2]

Haemophilia

Volumn 9, Issue 6, 2003, Pages 745-

  Brown, Simon A ^a   Yee, T T ^a   Griffioen, A ^a   Lee, C A ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

B DOMAIN DELETED FACTOR VIII; B-DOMAIN-DELETED FACTOR VIII; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; PEPTIDE FRAGMENT; RECOMBINANT BLOOD CLOTTING FACTOR 8;

CHILD; COHORT ANALYSIS; COMPARATIVE STUDY; DATA ANALYSIS; DRUG EFFICACY; GENE DELETION; HEMARTHROSIS; HEMOPHILIA A; HEMOPHILIA B; HUMAN; LETTER; PRIORITY JOURNAL; PROTEIN DOMAIN; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

EID: 0347588508     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.2003.00805.x     Document Type: Letter

References (2)

1. Gruppo RA, Brown D, Wilkes MM, Navickis RJ. Comparative effectiveness of full-length and B-domain deleted factor VIII for prophylaxis - a meta-analysis. Haemophilia 2003; 9: 251-60.
2. Yee TT, Beeton K, Griffioen A et al. Experience of prophylaxis treatment in children with severe haemophilia. Haemophilia 2002; 8: 76-82.